上腺素在败血症休克治疗中的应用:一个元分析
Qiu Ying Xu1, Yan Hong Jin2, Li Fu2
1Department of Intensive Care Unit, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China. xuqiuying3271@163.com.
Irish journal of medical science
|November 8, 2024
概括
上腺素有效地减少了28天的死亡率和重症监护室 (ICU) 停留时间,在患有败血性休克的患者中. 这种血管压缩剂还可以降低心律失常的发生率,使其成为首选的治疗选择.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 败血性休克是一种危及生命的疾病,需要立即提供血液动力学支持.
- 血管压缩剂在治疗败血症休克方面至关重要,而诺拉皮内林是常用的药物.
研究的目的:
- 系统地评估北上腺素在治疗败血症休克时的疗效和安全性.
- 为了比较与上腺素与其他血管抑制剂或安慰剂相关的结果.
主要方法:
- 进行了随机对照试验 (RCT) 的元分析.
- 文献搜索包括到2023年10月1日的PubMed,科学网和Medline.
- 科克兰风险偏差工具评估了研究质量;RevMan 5.3软件进行了元分析.
主要成果:
- 上腺素显著降低了28天死亡率 (RR=0.92) 和心律失常的发生率 (RR=0.54).
- 在北上腺素组 (MD=-1.03天) 中,重症监护室 (ICU) 停留时间明显较短.
- 在住院死亡率,90天死亡率,整体住院时间或达到目标平均动脉压 (MAP) 方面没有发现显著差异.
结论:
- 上腺素在改善28天生存率和减少感染性休克患者的ICU停留时间方面表现出优势.
- 在使用北上腺素时,心律失常的发生率显著较低.
- 上腺素是感染性休克的有效治疗选择,与其他血管压缩剂相比,具有优势.
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
731
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
731
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:16Antianginal Drugs: Nitrates and β-Blockers
525
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
525
01:22Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
01:18Adrenergic Agonists: Therapeutic Classification
722
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
722